Kura Oncology, Inc. (KURA)

Kura Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	37.32	51.8	90.88	325.7	26.14
Short-Term Investments	386.64	386.18	427.29	307.83	210.76
Cash & Cash Equivalents	423.96	437.99	518.17	633.53	236.89
Cash Growth	-3.20%	-15.47%	-18.21%	167.44%	32.35%
Other Current Assets	8.52	8.44	4.12	3.76	2.71
Total Current Assets	432.48	446.43	522.29	637.29	239.6
Property, Plant & Equipment	8.85	6.38	8.25	8.36	0.28
Other Long-Term Assets	7.6	3.5	3.52	1.57	2.09
Total Long-Term Assets	16.45	9.88	11.76	9.92	2.37
Total Assets	448.94	456.31	534.05	647.21	241.97
Accounts Payable	33.76	21.74	20.19	23.02	15.31
Current Debt	1.51	2.32	2.26	3	0.25
Total Current Liabilities	35.26	24.06	22.46	26.02	15.56
Long-Term Debt	15.69	11.71	4.61	9.89	7.25
Other Long-Term Liabilities	0.71	0.27	0.38	0.4	0.38
Total Long-Term Liabilities	16.4	11.97	4.99	10.28	7.63
Total Liabilities	51.66	36.03	27.44	36.31	23.19
Total Debt	17.2	14.02	6.88	12.89	7.5
Debt Growth	22.65%	103.99%	-46.66%	71.84%	-
Retained Earnings	-721.44	-568.81	-432.97	-302.5	-212.88
Comprehensive Income	-1.27	-8.03	-1.79	0.05	0.33
Shareholders' Equity	397.27	420.28	506.61	610.91	218.78
Net Cash / Debt	406.76	423.96	511.3	620.64	229.39
Net Cash / Debt Growth	-4.06%	-17.08%	-17.62%	170.56%	33.77%
Net Cash Per Share	5.55	6.33	7.71	11.69	5.47
Working Capital	397.22	422.37	499.83	611.27	224.04
Book Value Per Share	5.42	6.27	7.63	11.51	5.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).